Strategic Acquisitions Revolution Medicines has been actively acquiring companies like Pharmatching GmbH and NS Healthcare, indicating a focus on expanding their portfolio and capabilities which can present cross-selling opportunities for related products and services.
Cutting-Edge Therapies Revolution Medicines is dedicated to developing innovative therapies for RAS-addicted cancers, showcasing a commitment to breakthrough solutions that can attract partnerships or collaborations with organizations seeking novel treatment options.
Financial Stability With a revenue range of $50M - $100M and a funding amount of $324M, Revolution Medicines demonstrates financial strength, making them an attractive potential client for service providers looking to engage with well-funded companies in the biotechnology sector.
Key Personnel Expansion The addition of Lorence Kim to Revolution Medicines' board of directors brings valuable expertise to the company, presenting an opportunity for business development professionals to leverage connections and networks of key personnel for potential partnerships or business engagements.
Technology Adoption Revolution Medicines utilizes a tech stack including Varnish, Docker, and Microsoft tools, indicating a sophisticated technology infrastructure. This presents an opportunity for tech solution providers to offer complementary services or products to enhance the company's operations.
66
966
$100M$1B
160$10M$50M
146$10M$50M
413$50M$100M
114$10M$50M
11
731$100M$1B
201$50M$100MRevolution Medicines uses 8 technology products and services including Varnish, Kubernetes, Microsoft Excel, and more. Explore Revolution Medicines's tech stack below.
| Revolution Medicines Email Formats | Percentage |
| FLast@revolutionmedicines.com | 53% |
| First@revolutionmedicines.com | 39% |
| First.Last@revolutionmedicines.com | 4% |
| FL@revolutionmedicines.com | 2% |
| FiLast@revolutionmedicines.com | 1% |
| Last@revolutionmedicines.com | 1% |
| FLast@revmed.com | 77% |
| First@revmed.com | 22% |
| Last@revmed.com | 1% |
Biotechnology ResearchCalifornia, United States501-1000 Employees
We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses.
Company Overview
Funding & FinancialsRevolution Medicines has raised a total of $324M of funding over 8 rounds. Their latest funding round was raised on Mar 02, 2023 in the amount of $324M.
Revolution Medicines's revenue is in the range of $50M$100M
Funding & FinancialsRevolution Medicines has raised a total of $324M of funding over 8 rounds. Their latest funding round was raised on Mar 02, 2023 in the amount of $324M.
Revolution Medicines's revenue is in the range of $50M$100M
1-888-653-2347 
support@leadiq.com